mouse monoclonal anti-brafv600e antibody, clone ve1 (Spring Bioscience)
90
Structured Review
Spring Bioscience
mouse monoclonal anti-brafv600e antibody, clone ve1
Mouse Monoclonal Anti Brafv600e Antibody, Clone Ve1, supplied by Spring Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti-brafv600e+(ve1)+mouse+monoclonal+antibody/braf+v600e+antibody/10__1097_slash_pgp__0000000000000933-45-13-16
Average 90 stars, based on 1 article reviews
Mouse Monoclonal Anti Brafv600e Antibody, Clone Ve1, supplied by Spring Bioscience, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti-brafv600e+(ve1)+mouse+monoclonal+antibody/braf+v600e+antibody/10__1097_slash_pgp__0000000000000933-45-13-16
Average 90 stars, based on 1 article reviews
mouse monoclonal anti-brafv600e antibody, clone ve1 - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Immunohistochemical staining:Article Title: BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 8C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Article Title: Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Article Snippet: Background: The BRAFV600E mutation is the most common genetic alteration in papillary thyroid carcinoma (PTC).. The aim of this study is to analyze the clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry (IHC) and BRAF RNA in situ hybridization (ISH) in PTC.. Methods: This study included 467 patients with PTC who underwent surgical resection. Article Title: Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Article Snippet: The association of syringocystadenoma papilliferum with verrucous carcinoma of the skin in the same lesion is a rare, but well-documented event.. Although human papilloma viruses have been proposed to have an etiologic role in the development of the verrucous proliferations associated with syringocystadenoma papilliferum, most of the immunohistochemical and molecular studies have failed to demonstrate the presence of their genomic material in these lesions.. We report a series of 4 cases of syringocystadenoma papilliferum associated with verrucous carcinoma in anogenital lesions. Article Title: The landscape of BRAF transcript and protein variants in human cancer Article Snippet: They were then incubated overnight at 4 °C with the following primary antibodies: anti-BRAF (F-7, #5284, Santa Cruz Biotechnology; mouse monoclonal antibody, dilution 1:1000 in 5% milk in TBST); Article Title: Investigation of FOXM1 as a Potential New Target for Melanoma Article Snippet: Sections of paraffin-embedded melanomas and nevus tissue samples were stained with a monoclonal mouse anti-FOXM1 antibody (clone 3A9; Abnova, Taipei, Taiwan), Article Title: Sessile Serrated Polyps are Precursors of Colon Carcinomas Predominantly with Deficient DNA Mismatch Repair Article Snippet: Staining for BRAF was performed with a Article Title: Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer. Article Snippet: Background.. BRAF mutation has been investigated by immunohistochemistry and has shown high sensitivity and specificity.. We aim to investigate the accuracy of immunohistochemistry versus molecular testing of BRAF in papillary thyroid cancer using a large number of polymerase chain reaction–positive BRAF papillary thyroid cancer tissues. Article Title: BRAF V600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 °C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Expressing:Article Title: BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 8C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Article Title: Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Article Snippet: Background: The BRAFV600E mutation is the most common genetic alteration in papillary thyroid carcinoma (PTC).. The aim of this study is to analyze the clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry (IHC) and BRAF RNA in situ hybridization (ISH) in PTC.. Methods: This study included 467 patients with PTC who underwent surgical resection. Article Title: Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Article Snippet: The association of syringocystadenoma papilliferum with verrucous carcinoma of the skin in the same lesion is a rare, but well-documented event.. Although human papilloma viruses have been proposed to have an etiologic role in the development of the verrucous proliferations associated with syringocystadenoma papilliferum, most of the immunohistochemical and molecular studies have failed to demonstrate the presence of their genomic material in these lesions.. We report a series of 4 cases of syringocystadenoma papilliferum associated with verrucous carcinoma in anogenital lesions. Article Title: The landscape of BRAF transcript and protein variants in human cancer Article Snippet: They were then incubated overnight at 4 °C with the following primary antibodies: anti-BRAF (F-7, #5284, Santa Cruz Biotechnology; mouse monoclonal antibody, dilution 1:1000 in 5% milk in TBST); Article Title: Investigation of FOXM1 as a Potential New Target for Melanoma Article Snippet: Sections of paraffin-embedded melanomas and nevus tissue samples were stained with a monoclonal mouse anti-FOXM1 antibody (clone 3A9; Abnova, Taipei, Taiwan), Article Title: Sessile Serrated Polyps are Precursors of Colon Carcinomas Predominantly with Deficient DNA Mismatch Repair Article Snippet: Staining for BRAF was performed with a Article Title: Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer. Article Snippet: Background.. BRAF mutation has been investigated by immunohistochemistry and has shown high sensitivity and specificity.. We aim to investigate the accuracy of immunohistochemistry versus molecular testing of BRAF in papillary thyroid cancer using a large number of polymerase chain reaction–positive BRAF papillary thyroid cancer tissues. Article Title: BRAF V600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 °C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Staining:Article Title: BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 8C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Article Title: Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Article Snippet: Background: The BRAFV600E mutation is the most common genetic alteration in papillary thyroid carcinoma (PTC).. The aim of this study is to analyze the clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry (IHC) and BRAF RNA in situ hybridization (ISH) in PTC.. Methods: This study included 467 patients with PTC who underwent surgical resection. Article Title: Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Article Snippet: The association of syringocystadenoma papilliferum with verrucous carcinoma of the skin in the same lesion is a rare, but well-documented event.. Although human papilloma viruses have been proposed to have an etiologic role in the development of the verrucous proliferations associated with syringocystadenoma papilliferum, most of the immunohistochemical and molecular studies have failed to demonstrate the presence of their genomic material in these lesions.. We report a series of 4 cases of syringocystadenoma papilliferum associated with verrucous carcinoma in anogenital lesions. Article Title: The landscape of BRAF transcript and protein variants in human cancer Article Snippet: They were then incubated overnight at 4 °C with the following primary antibodies: anti-BRAF (F-7, #5284, Santa Cruz Biotechnology; mouse monoclonal antibody, dilution 1:1000 in 5% milk in TBST); Article Title: Investigation of FOXM1 as a Potential New Target for Melanoma Article Snippet: Sections of paraffin-embedded melanomas and nevus tissue samples were stained with a monoclonal mouse anti-FOXM1 antibody (clone 3A9; Abnova, Taipei, Taiwan), Article Title: Sessile Serrated Polyps are Precursors of Colon Carcinomas Predominantly with Deficient DNA Mismatch Repair Article Snippet: Staining for BRAF was performed with a Article Title: Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer. Article Snippet: Background.. BRAF mutation has been investigated by immunohistochemistry and has shown high sensitivity and specificity.. We aim to investigate the accuracy of immunohistochemistry versus molecular testing of BRAF in papillary thyroid cancer using a large number of polymerase chain reaction–positive BRAF papillary thyroid cancer tissues. Article Title: BRAF V600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 °C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Derivative Assay:Article Title: BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 8C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Article Title: Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Article Snippet: Background: The BRAFV600E mutation is the most common genetic alteration in papillary thyroid carcinoma (PTC).. The aim of this study is to analyze the clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry (IHC) and BRAF RNA in situ hybridization (ISH) in PTC.. Methods: This study included 467 patients with PTC who underwent surgical resection. Article Title: Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Article Snippet: The association of syringocystadenoma papilliferum with verrucous carcinoma of the skin in the same lesion is a rare, but well-documented event.. Although human papilloma viruses have been proposed to have an etiologic role in the development of the verrucous proliferations associated with syringocystadenoma papilliferum, most of the immunohistochemical and molecular studies have failed to demonstrate the presence of their genomic material in these lesions.. We report a series of 4 cases of syringocystadenoma papilliferum associated with verrucous carcinoma in anogenital lesions. Article Title: The landscape of BRAF transcript and protein variants in human cancer Article Snippet: They were then incubated overnight at 4 °C with the following primary antibodies: anti-BRAF (F-7, #5284, Santa Cruz Biotechnology; mouse monoclonal antibody, dilution 1:1000 in 5% milk in TBST); Article Title: Investigation of FOXM1 as a Potential New Target for Melanoma Article Snippet: Sections of paraffin-embedded melanomas and nevus tissue samples were stained with a monoclonal mouse anti-FOXM1 antibody (clone 3A9; Abnova, Taipei, Taiwan), Article Title: Sessile Serrated Polyps are Precursors of Colon Carcinomas Predominantly with Deficient DNA Mismatch Repair Article Snippet: Staining for BRAF was performed with a Article Title: Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer. Article Snippet: Background.. BRAF mutation has been investigated by immunohistochemistry and has shown high sensitivity and specificity.. We aim to investigate the accuracy of immunohistochemistry versus molecular testing of BRAF in papillary thyroid cancer using a large number of polymerase chain reaction–positive BRAF papillary thyroid cancer tissues. Article Title: BRAF V600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 °C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Incubation:Article Title: BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 8C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Article Title: Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Article Snippet: Background: The BRAFV600E mutation is the most common genetic alteration in papillary thyroid carcinoma (PTC).. The aim of this study is to analyze the clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry (IHC) and BRAF RNA in situ hybridization (ISH) in PTC.. Methods: This study included 467 patients with PTC who underwent surgical resection. Article Title: Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Article Snippet: The association of syringocystadenoma papilliferum with verrucous carcinoma of the skin in the same lesion is a rare, but well-documented event.. Although human papilloma viruses have been proposed to have an etiologic role in the development of the verrucous proliferations associated with syringocystadenoma papilliferum, most of the immunohistochemical and molecular studies have failed to demonstrate the presence of their genomic material in these lesions.. We report a series of 4 cases of syringocystadenoma papilliferum associated with verrucous carcinoma in anogenital lesions. Article Title: The landscape of BRAF transcript and protein variants in human cancer Article Snippet: They were then incubated overnight at 4 °C with the following primary antibodies: anti-BRAF (F-7, #5284, Santa Cruz Biotechnology; mouse monoclonal antibody, dilution 1:1000 in 5% milk in TBST); Article Title: Investigation of FOXM1 as a Potential New Target for Melanoma Article Snippet: Sections of paraffin-embedded melanomas and nevus tissue samples were stained with a monoclonal mouse anti-FOXM1 antibody (clone 3A9; Abnova, Taipei, Taiwan), Article Title: Sessile Serrated Polyps are Precursors of Colon Carcinomas Predominantly with Deficient DNA Mismatch Repair Article Snippet: Staining for BRAF was performed with a Article Title: Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer. Article Snippet: Background.. BRAF mutation has been investigated by immunohistochemistry and has shown high sensitivity and specificity.. We aim to investigate the accuracy of immunohistochemistry versus molecular testing of BRAF in papillary thyroid cancer using a large number of polymerase chain reaction–positive BRAF papillary thyroid cancer tissues. Article Title: BRAF V600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 °C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Real-time Polymerase Chain Reaction:Article Title: BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 8C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Article Title: Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Article Snippet: Background: The BRAFV600E mutation is the most common genetic alteration in papillary thyroid carcinoma (PTC).. The aim of this study is to analyze the clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry (IHC) and BRAF RNA in situ hybridization (ISH) in PTC.. Methods: This study included 467 patients with PTC who underwent surgical resection. Article Title: Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Article Snippet: The association of syringocystadenoma papilliferum with verrucous carcinoma of the skin in the same lesion is a rare, but well-documented event.. Although human papilloma viruses have been proposed to have an etiologic role in the development of the verrucous proliferations associated with syringocystadenoma papilliferum, most of the immunohistochemical and molecular studies have failed to demonstrate the presence of their genomic material in these lesions.. We report a series of 4 cases of syringocystadenoma papilliferum associated with verrucous carcinoma in anogenital lesions. Article Title: The landscape of BRAF transcript and protein variants in human cancer Article Snippet: They were then incubated overnight at 4 °C with the following primary antibodies: anti-BRAF (F-7, #5284, Santa Cruz Biotechnology; mouse monoclonal antibody, dilution 1:1000 in 5% milk in TBST); Article Title: Investigation of FOXM1 as a Potential New Target for Melanoma Article Snippet: Sections of paraffin-embedded melanomas and nevus tissue samples were stained with a monoclonal mouse anti-FOXM1 antibody (clone 3A9; Abnova, Taipei, Taiwan), Article Title: Sessile Serrated Polyps are Precursors of Colon Carcinomas Predominantly with Deficient DNA Mismatch Repair Article Snippet: Staining for BRAF was performed with a Article Title: Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer. Article Snippet: Background.. BRAF mutation has been investigated by immunohistochemistry and has shown high sensitivity and specificity.. We aim to investigate the accuracy of immunohistochemistry versus molecular testing of BRAF in papillary thyroid cancer using a large number of polymerase chain reaction–positive BRAF papillary thyroid cancer tissues. Article Title: BRAF V600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 °C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Amplification:Article Title: BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 8C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Article Title: Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Article Snippet: Background: The BRAFV600E mutation is the most common genetic alteration in papillary thyroid carcinoma (PTC).. The aim of this study is to analyze the clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry (IHC) and BRAF RNA in situ hybridization (ISH) in PTC.. Methods: This study included 467 patients with PTC who underwent surgical resection. Article Title: Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Article Snippet: The association of syringocystadenoma papilliferum with verrucous carcinoma of the skin in the same lesion is a rare, but well-documented event.. Although human papilloma viruses have been proposed to have an etiologic role in the development of the verrucous proliferations associated with syringocystadenoma papilliferum, most of the immunohistochemical and molecular studies have failed to demonstrate the presence of their genomic material in these lesions.. We report a series of 4 cases of syringocystadenoma papilliferum associated with verrucous carcinoma in anogenital lesions. Article Title: The landscape of BRAF transcript and protein variants in human cancer Article Snippet: They were then incubated overnight at 4 °C with the following primary antibodies: anti-BRAF (F-7, #5284, Santa Cruz Biotechnology; mouse monoclonal antibody, dilution 1:1000 in 5% milk in TBST); Article Title: Investigation of FOXM1 as a Potential New Target for Melanoma Article Snippet: Sections of paraffin-embedded melanomas and nevus tissue samples were stained with a monoclonal mouse anti-FOXM1 antibody (clone 3A9; Abnova, Taipei, Taiwan), Article Title: Sessile Serrated Polyps are Precursors of Colon Carcinomas Predominantly with Deficient DNA Mismatch Repair Article Snippet: Staining for BRAF was performed with a Article Title: Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer. Article Snippet: Background.. BRAF mutation has been investigated by immunohistochemistry and has shown high sensitivity and specificity.. We aim to investigate the accuracy of immunohistochemistry versus molecular testing of BRAF in papillary thyroid cancer using a large number of polymerase chain reaction–positive BRAF papillary thyroid cancer tissues. Article Title: BRAF V600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 °C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Variant Assay:Article Title: BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 8C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Article Title: Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Article Snippet: Background: The BRAFV600E mutation is the most common genetic alteration in papillary thyroid carcinoma (PTC).. The aim of this study is to analyze the clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry (IHC) and BRAF RNA in situ hybridization (ISH) in PTC.. Methods: This study included 467 patients with PTC who underwent surgical resection. Article Title: Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Article Snippet: The association of syringocystadenoma papilliferum with verrucous carcinoma of the skin in the same lesion is a rare, but well-documented event.. Although human papilloma viruses have been proposed to have an etiologic role in the development of the verrucous proliferations associated with syringocystadenoma papilliferum, most of the immunohistochemical and molecular studies have failed to demonstrate the presence of their genomic material in these lesions.. We report a series of 4 cases of syringocystadenoma papilliferum associated with verrucous carcinoma in anogenital lesions. Article Title: The landscape of BRAF transcript and protein variants in human cancer Article Snippet: They were then incubated overnight at 4 °C with the following primary antibodies: anti-BRAF (F-7, #5284, Santa Cruz Biotechnology; mouse monoclonal antibody, dilution 1:1000 in 5% milk in TBST); Article Title: Investigation of FOXM1 as a Potential New Target for Melanoma Article Snippet: Sections of paraffin-embedded melanomas and nevus tissue samples were stained with a monoclonal mouse anti-FOXM1 antibody (clone 3A9; Abnova, Taipei, Taiwan), Article Title: Sessile Serrated Polyps are Precursors of Colon Carcinomas Predominantly with Deficient DNA Mismatch Repair Article Snippet: Staining for BRAF was performed with a Article Title: Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer. Article Snippet: Background.. BRAF mutation has been investigated by immunohistochemistry and has shown high sensitivity and specificity.. We aim to investigate the accuracy of immunohistochemistry versus molecular testing of BRAF in papillary thyroid cancer using a large number of polymerase chain reaction–positive BRAF papillary thyroid cancer tissues. Article Title: BRAF V600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 °C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Plasmid Preparation:Article Title: BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 8C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Article Title: Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Article Snippet: Background: The BRAFV600E mutation is the most common genetic alteration in papillary thyroid carcinoma (PTC).. The aim of this study is to analyze the clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry (IHC) and BRAF RNA in situ hybridization (ISH) in PTC.. Methods: This study included 467 patients with PTC who underwent surgical resection. Article Title: Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Article Snippet: The association of syringocystadenoma papilliferum with verrucous carcinoma of the skin in the same lesion is a rare, but well-documented event.. Although human papilloma viruses have been proposed to have an etiologic role in the development of the verrucous proliferations associated with syringocystadenoma papilliferum, most of the immunohistochemical and molecular studies have failed to demonstrate the presence of their genomic material in these lesions.. We report a series of 4 cases of syringocystadenoma papilliferum associated with verrucous carcinoma in anogenital lesions. Article Title: The landscape of BRAF transcript and protein variants in human cancer Article Snippet: They were then incubated overnight at 4 °C with the following primary antibodies: anti-BRAF (F-7, #5284, Santa Cruz Biotechnology; mouse monoclonal antibody, dilution 1:1000 in 5% milk in TBST); Article Title: Investigation of FOXM1 as a Potential New Target for Melanoma Article Snippet: Sections of paraffin-embedded melanomas and nevus tissue samples were stained with a monoclonal mouse anti-FOXM1 antibody (clone 3A9; Abnova, Taipei, Taiwan), Article Title: Sessile Serrated Polyps are Precursors of Colon Carcinomas Predominantly with Deficient DNA Mismatch Repair Article Snippet: Staining for BRAF was performed with a Article Title: Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer. Article Snippet: Background.. BRAF mutation has been investigated by immunohistochemistry and has shown high sensitivity and specificity.. We aim to investigate the accuracy of immunohistochemistry versus molecular testing of BRAF in papillary thyroid cancer using a large number of polymerase chain reaction–positive BRAF papillary thyroid cancer tissues. Article Title: BRAF V600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 °C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Positive Control:Article Title: BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 8C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Article Title: Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Article Snippet: Background: The BRAFV600E mutation is the most common genetic alteration in papillary thyroid carcinoma (PTC).. The aim of this study is to analyze the clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry (IHC) and BRAF RNA in situ hybridization (ISH) in PTC.. Methods: This study included 467 patients with PTC who underwent surgical resection. Article Title: Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Article Snippet: The association of syringocystadenoma papilliferum with verrucous carcinoma of the skin in the same lesion is a rare, but well-documented event.. Although human papilloma viruses have been proposed to have an etiologic role in the development of the verrucous proliferations associated with syringocystadenoma papilliferum, most of the immunohistochemical and molecular studies have failed to demonstrate the presence of their genomic material in these lesions.. We report a series of 4 cases of syringocystadenoma papilliferum associated with verrucous carcinoma in anogenital lesions. Article Title: The landscape of BRAF transcript and protein variants in human cancer Article Snippet: They were then incubated overnight at 4 °C with the following primary antibodies: anti-BRAF (F-7, #5284, Santa Cruz Biotechnology; mouse monoclonal antibody, dilution 1:1000 in 5% milk in TBST); Article Title: Investigation of FOXM1 as a Potential New Target for Melanoma Article Snippet: Sections of paraffin-embedded melanomas and nevus tissue samples were stained with a monoclonal mouse anti-FOXM1 antibody (clone 3A9; Abnova, Taipei, Taiwan), Article Title: Sessile Serrated Polyps are Precursors of Colon Carcinomas Predominantly with Deficient DNA Mismatch Repair Article Snippet: Staining for BRAF was performed with a Article Title: Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer. Article Snippet: Background.. BRAF mutation has been investigated by immunohistochemistry and has shown high sensitivity and specificity.. We aim to investigate the accuracy of immunohistochemistry versus molecular testing of BRAF in papillary thyroid cancer using a large number of polymerase chain reaction–positive BRAF papillary thyroid cancer tissues. Article Title: BRAF V600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 °C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Transfection:Article Title: BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 8C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Article Title: Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Article Snippet: Background: The BRAFV600E mutation is the most common genetic alteration in papillary thyroid carcinoma (PTC).. The aim of this study is to analyze the clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry (IHC) and BRAF RNA in situ hybridization (ISH) in PTC.. Methods: This study included 467 patients with PTC who underwent surgical resection. Article Title: Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Article Snippet: The association of syringocystadenoma papilliferum with verrucous carcinoma of the skin in the same lesion is a rare, but well-documented event.. Although human papilloma viruses have been proposed to have an etiologic role in the development of the verrucous proliferations associated with syringocystadenoma papilliferum, most of the immunohistochemical and molecular studies have failed to demonstrate the presence of their genomic material in these lesions.. We report a series of 4 cases of syringocystadenoma papilliferum associated with verrucous carcinoma in anogenital lesions. Article Title: The landscape of BRAF transcript and protein variants in human cancer Article Snippet: They were then incubated overnight at 4 °C with the following primary antibodies: anti-BRAF (F-7, #5284, Santa Cruz Biotechnology; mouse monoclonal antibody, dilution 1:1000 in 5% milk in TBST); Article Title: Investigation of FOXM1 as a Potential New Target for Melanoma Article Snippet: Sections of paraffin-embedded melanomas and nevus tissue samples were stained with a monoclonal mouse anti-FOXM1 antibody (clone 3A9; Abnova, Taipei, Taiwan), Article Title: Sessile Serrated Polyps are Precursors of Colon Carcinomas Predominantly with Deficient DNA Mismatch Repair Article Snippet: Staining for BRAF was performed with a Article Title: Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer. Article Snippet: Background.. BRAF mutation has been investigated by immunohistochemistry and has shown high sensitivity and specificity.. We aim to investigate the accuracy of immunohistochemistry versus molecular testing of BRAF in papillary thyroid cancer using a large number of polymerase chain reaction–positive BRAF papillary thyroid cancer tissues. Article Title: BRAF V600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 °C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Western Blot:Article Title: BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 8C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Article Title: Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Article Snippet: Background: The BRAFV600E mutation is the most common genetic alteration in papillary thyroid carcinoma (PTC).. The aim of this study is to analyze the clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry (IHC) and BRAF RNA in situ hybridization (ISH) in PTC.. Methods: This study included 467 patients with PTC who underwent surgical resection. Article Title: Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Article Snippet: The association of syringocystadenoma papilliferum with verrucous carcinoma of the skin in the same lesion is a rare, but well-documented event.. Although human papilloma viruses have been proposed to have an etiologic role in the development of the verrucous proliferations associated with syringocystadenoma papilliferum, most of the immunohistochemical and molecular studies have failed to demonstrate the presence of their genomic material in these lesions.. We report a series of 4 cases of syringocystadenoma papilliferum associated with verrucous carcinoma in anogenital lesions. Article Title: The landscape of BRAF transcript and protein variants in human cancer Article Snippet: They were then incubated overnight at 4 °C with the following primary antibodies: anti-BRAF (F-7, #5284, Santa Cruz Biotechnology; mouse monoclonal antibody, dilution 1:1000 in 5% milk in TBST); Article Title: Investigation of FOXM1 as a Potential New Target for Melanoma Article Snippet: Sections of paraffin-embedded melanomas and nevus tissue samples were stained with a monoclonal mouse anti-FOXM1 antibody (clone 3A9; Abnova, Taipei, Taiwan), Article Title: Sessile Serrated Polyps are Precursors of Colon Carcinomas Predominantly with Deficient DNA Mismatch Repair Article Snippet: Staining for BRAF was performed with a Article Title: Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer. Article Snippet: Background.. BRAF mutation has been investigated by immunohistochemistry and has shown high sensitivity and specificity.. We aim to investigate the accuracy of immunohistochemistry versus molecular testing of BRAF in papillary thyroid cancer using a large number of polymerase chain reaction–positive BRAF papillary thyroid cancer tissues. Article Title: BRAF V600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 °C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Colony Assay:Article Title: BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 8C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Article Title: Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Article Snippet: Background: The BRAFV600E mutation is the most common genetic alteration in papillary thyroid carcinoma (PTC).. The aim of this study is to analyze the clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry (IHC) and BRAF RNA in situ hybridization (ISH) in PTC.. Methods: This study included 467 patients with PTC who underwent surgical resection. Article Title: Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Article Snippet: The association of syringocystadenoma papilliferum with verrucous carcinoma of the skin in the same lesion is a rare, but well-documented event.. Although human papilloma viruses have been proposed to have an etiologic role in the development of the verrucous proliferations associated with syringocystadenoma papilliferum, most of the immunohistochemical and molecular studies have failed to demonstrate the presence of their genomic material in these lesions.. We report a series of 4 cases of syringocystadenoma papilliferum associated with verrucous carcinoma in anogenital lesions. Article Title: The landscape of BRAF transcript and protein variants in human cancer Article Snippet: They were then incubated overnight at 4 °C with the following primary antibodies: anti-BRAF (F-7, #5284, Santa Cruz Biotechnology; mouse monoclonal antibody, dilution 1:1000 in 5% milk in TBST); Article Title: Investigation of FOXM1 as a Potential New Target for Melanoma Article Snippet: Sections of paraffin-embedded melanomas and nevus tissue samples were stained with a monoclonal mouse anti-FOXM1 antibody (clone 3A9; Abnova, Taipei, Taiwan), Article Title: Sessile Serrated Polyps are Precursors of Colon Carcinomas Predominantly with Deficient DNA Mismatch Repair Article Snippet: Staining for BRAF was performed with a Article Title: Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer. Article Snippet: Background.. BRAF mutation has been investigated by immunohistochemistry and has shown high sensitivity and specificity.. We aim to investigate the accuracy of immunohistochemistry versus molecular testing of BRAF in papillary thyroid cancer using a large number of polymerase chain reaction–positive BRAF papillary thyroid cancer tissues. Article Title: BRAF V600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 °C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Immunoprecipitation:Article Title: BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 8C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Article Title: Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Article Snippet: Background: The BRAFV600E mutation is the most common genetic alteration in papillary thyroid carcinoma (PTC).. The aim of this study is to analyze the clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry (IHC) and BRAF RNA in situ hybridization (ISH) in PTC.. Methods: This study included 467 patients with PTC who underwent surgical resection. Article Title: Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Article Snippet: The association of syringocystadenoma papilliferum with verrucous carcinoma of the skin in the same lesion is a rare, but well-documented event.. Although human papilloma viruses have been proposed to have an etiologic role in the development of the verrucous proliferations associated with syringocystadenoma papilliferum, most of the immunohistochemical and molecular studies have failed to demonstrate the presence of their genomic material in these lesions.. We report a series of 4 cases of syringocystadenoma papilliferum associated with verrucous carcinoma in anogenital lesions. Article Title: The landscape of BRAF transcript and protein variants in human cancer Article Snippet: They were then incubated overnight at 4 °C with the following primary antibodies: anti-BRAF (F-7, #5284, Santa Cruz Biotechnology; mouse monoclonal antibody, dilution 1:1000 in 5% milk in TBST); Article Title: Investigation of FOXM1 as a Potential New Target for Melanoma Article Snippet: Sections of paraffin-embedded melanomas and nevus tissue samples were stained with a monoclonal mouse anti-FOXM1 antibody (clone 3A9; Abnova, Taipei, Taiwan), Article Title: Sessile Serrated Polyps are Precursors of Colon Carcinomas Predominantly with Deficient DNA Mismatch Repair Article Snippet: Staining for BRAF was performed with a Article Title: Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer. Article Snippet: Background.. BRAF mutation has been investigated by immunohistochemistry and has shown high sensitivity and specificity.. We aim to investigate the accuracy of immunohistochemistry versus molecular testing of BRAF in papillary thyroid cancer using a large number of polymerase chain reaction–positive BRAF papillary thyroid cancer tissues. Article Title: BRAF V600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 °C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Negative Control:Article Title: BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 8C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Article Title: Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Article Snippet: Background: The BRAFV600E mutation is the most common genetic alteration in papillary thyroid carcinoma (PTC).. The aim of this study is to analyze the clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry (IHC) and BRAF RNA in situ hybridization (ISH) in PTC.. Methods: This study included 467 patients with PTC who underwent surgical resection. Article Title: Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Article Snippet: The association of syringocystadenoma papilliferum with verrucous carcinoma of the skin in the same lesion is a rare, but well-documented event.. Although human papilloma viruses have been proposed to have an etiologic role in the development of the verrucous proliferations associated with syringocystadenoma papilliferum, most of the immunohistochemical and molecular studies have failed to demonstrate the presence of their genomic material in these lesions.. We report a series of 4 cases of syringocystadenoma papilliferum associated with verrucous carcinoma in anogenital lesions. Article Title: The landscape of BRAF transcript and protein variants in human cancer Article Snippet: They were then incubated overnight at 4 °C with the following primary antibodies: anti-BRAF (F-7, #5284, Santa Cruz Biotechnology; mouse monoclonal antibody, dilution 1:1000 in 5% milk in TBST); Article Title: Investigation of FOXM1 as a Potential New Target for Melanoma Article Snippet: Sections of paraffin-embedded melanomas and nevus tissue samples were stained with a monoclonal mouse anti-FOXM1 antibody (clone 3A9; Abnova, Taipei, Taiwan), Article Title: Sessile Serrated Polyps are Precursors of Colon Carcinomas Predominantly with Deficient DNA Mismatch Repair Article Snippet: Staining for BRAF was performed with a Article Title: Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer. Article Snippet: Background.. BRAF mutation has been investigated by immunohistochemistry and has shown high sensitivity and specificity.. We aim to investigate the accuracy of immunohistochemistry versus molecular testing of BRAF in papillary thyroid cancer using a large number of polymerase chain reaction–positive BRAF papillary thyroid cancer tissues. Article Title: BRAF V600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 °C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Mass Spectrometry:Article Title: BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 8C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Article Title: Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Article Snippet: Background: The BRAFV600E mutation is the most common genetic alteration in papillary thyroid carcinoma (PTC).. The aim of this study is to analyze the clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry (IHC) and BRAF RNA in situ hybridization (ISH) in PTC.. Methods: This study included 467 patients with PTC who underwent surgical resection. Article Title: Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Article Snippet: The association of syringocystadenoma papilliferum with verrucous carcinoma of the skin in the same lesion is a rare, but well-documented event.. Although human papilloma viruses have been proposed to have an etiologic role in the development of the verrucous proliferations associated with syringocystadenoma papilliferum, most of the immunohistochemical and molecular studies have failed to demonstrate the presence of their genomic material in these lesions.. We report a series of 4 cases of syringocystadenoma papilliferum associated with verrucous carcinoma in anogenital lesions. Article Title: The landscape of BRAF transcript and protein variants in human cancer Article Snippet: They were then incubated overnight at 4 °C with the following primary antibodies: anti-BRAF (F-7, #5284, Santa Cruz Biotechnology; mouse monoclonal antibody, dilution 1:1000 in 5% milk in TBST); Article Title: Investigation of FOXM1 as a Potential New Target for Melanoma Article Snippet: Sections of paraffin-embedded melanomas and nevus tissue samples were stained with a monoclonal mouse anti-FOXM1 antibody (clone 3A9; Abnova, Taipei, Taiwan), Article Title: Sessile Serrated Polyps are Precursors of Colon Carcinomas Predominantly with Deficient DNA Mismatch Repair Article Snippet: Staining for BRAF was performed with a Article Title: Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer. Article Snippet: Background.. BRAF mutation has been investigated by immunohistochemistry and has shown high sensitivity and specificity.. We aim to investigate the accuracy of immunohistochemistry versus molecular testing of BRAF in papillary thyroid cancer using a large number of polymerase chain reaction–positive BRAF papillary thyroid cancer tissues. Article Title: BRAF V600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 °C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Liquid Chromatography with Mass Spectroscopy:Article Title: BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 8C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Article Title: Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Article Snippet: Background: The BRAFV600E mutation is the most common genetic alteration in papillary thyroid carcinoma (PTC).. The aim of this study is to analyze the clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry (IHC) and BRAF RNA in situ hybridization (ISH) in PTC.. Methods: This study included 467 patients with PTC who underwent surgical resection. Article Title: Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Article Snippet: The association of syringocystadenoma papilliferum with verrucous carcinoma of the skin in the same lesion is a rare, but well-documented event.. Although human papilloma viruses have been proposed to have an etiologic role in the development of the verrucous proliferations associated with syringocystadenoma papilliferum, most of the immunohistochemical and molecular studies have failed to demonstrate the presence of their genomic material in these lesions.. We report a series of 4 cases of syringocystadenoma papilliferum associated with verrucous carcinoma in anogenital lesions. Article Title: The landscape of BRAF transcript and protein variants in human cancer Article Snippet: They were then incubated overnight at 4 °C with the following primary antibodies: anti-BRAF (F-7, #5284, Santa Cruz Biotechnology; mouse monoclonal antibody, dilution 1:1000 in 5% milk in TBST); Article Title: Investigation of FOXM1 as a Potential New Target for Melanoma Article Snippet: Sections of paraffin-embedded melanomas and nevus tissue samples were stained with a monoclonal mouse anti-FOXM1 antibody (clone 3A9; Abnova, Taipei, Taiwan), Article Title: Sessile Serrated Polyps are Precursors of Colon Carcinomas Predominantly with Deficient DNA Mismatch Repair Article Snippet: Staining for BRAF was performed with a Article Title: Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer. Article Snippet: Background.. BRAF mutation has been investigated by immunohistochemistry and has shown high sensitivity and specificity.. We aim to investigate the accuracy of immunohistochemistry versus molecular testing of BRAF in papillary thyroid cancer using a large number of polymerase chain reaction–positive BRAF papillary thyroid cancer tissues. Article Title: BRAF V600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 °C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Infection:Article Title: BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 8C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Article Title: Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Article Snippet: Background: The BRAFV600E mutation is the most common genetic alteration in papillary thyroid carcinoma (PTC).. The aim of this study is to analyze the clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry (IHC) and BRAF RNA in situ hybridization (ISH) in PTC.. Methods: This study included 467 patients with PTC who underwent surgical resection. Article Title: Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Article Snippet: The association of syringocystadenoma papilliferum with verrucous carcinoma of the skin in the same lesion is a rare, but well-documented event.. Although human papilloma viruses have been proposed to have an etiologic role in the development of the verrucous proliferations associated with syringocystadenoma papilliferum, most of the immunohistochemical and molecular studies have failed to demonstrate the presence of their genomic material in these lesions.. We report a series of 4 cases of syringocystadenoma papilliferum associated with verrucous carcinoma in anogenital lesions. Article Title: The landscape of BRAF transcript and protein variants in human cancer Article Snippet: They were then incubated overnight at 4 °C with the following primary antibodies: anti-BRAF (F-7, #5284, Santa Cruz Biotechnology; mouse monoclonal antibody, dilution 1:1000 in 5% milk in TBST); Article Title: Investigation of FOXM1 as a Potential New Target for Melanoma Article Snippet: Sections of paraffin-embedded melanomas and nevus tissue samples were stained with a monoclonal mouse anti-FOXM1 antibody (clone 3A9; Abnova, Taipei, Taiwan), Article Title: Sessile Serrated Polyps are Precursors of Colon Carcinomas Predominantly with Deficient DNA Mismatch Repair Article Snippet: Staining for BRAF was performed with a Article Title: Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer. Article Snippet: Background.. BRAF mutation has been investigated by immunohistochemistry and has shown high sensitivity and specificity.. We aim to investigate the accuracy of immunohistochemistry versus molecular testing of BRAF in papillary thyroid cancer using a large number of polymerase chain reaction–positive BRAF papillary thyroid cancer tissues. Article Title: BRAF V600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 °C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Sequencing:Article Title: BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 8C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Article Title: Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Article Snippet: Background: The BRAFV600E mutation is the most common genetic alteration in papillary thyroid carcinoma (PTC).. The aim of this study is to analyze the clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry (IHC) and BRAF RNA in situ hybridization (ISH) in PTC.. Methods: This study included 467 patients with PTC who underwent surgical resection. Article Title: Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Article Snippet: The association of syringocystadenoma papilliferum with verrucous carcinoma of the skin in the same lesion is a rare, but well-documented event.. Although human papilloma viruses have been proposed to have an etiologic role in the development of the verrucous proliferations associated with syringocystadenoma papilliferum, most of the immunohistochemical and molecular studies have failed to demonstrate the presence of their genomic material in these lesions.. We report a series of 4 cases of syringocystadenoma papilliferum associated with verrucous carcinoma in anogenital lesions. Article Title: The landscape of BRAF transcript and protein variants in human cancer Article Snippet: They were then incubated overnight at 4 °C with the following primary antibodies: anti-BRAF (F-7, #5284, Santa Cruz Biotechnology; mouse monoclonal antibody, dilution 1:1000 in 5% milk in TBST); Article Title: Investigation of FOXM1 as a Potential New Target for Melanoma Article Snippet: Sections of paraffin-embedded melanomas and nevus tissue samples were stained with a monoclonal mouse anti-FOXM1 antibody (clone 3A9; Abnova, Taipei, Taiwan), Article Title: Sessile Serrated Polyps are Precursors of Colon Carcinomas Predominantly with Deficient DNA Mismatch Repair Article Snippet: Staining for BRAF was performed with a Article Title: Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer. Article Snippet: Background.. BRAF mutation has been investigated by immunohistochemistry and has shown high sensitivity and specificity.. We aim to investigate the accuracy of immunohistochemistry versus molecular testing of BRAF in papillary thyroid cancer using a large number of polymerase chain reaction–positive BRAF papillary thyroid cancer tissues. Article Title: BRAF V600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 °C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Mutagenesis:Article Title: BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 8C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Article Title: Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Article Snippet: Background: The BRAFV600E mutation is the most common genetic alteration in papillary thyroid carcinoma (PTC).. The aim of this study is to analyze the clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry (IHC) and BRAF RNA in situ hybridization (ISH) in PTC.. Methods: This study included 467 patients with PTC who underwent surgical resection. Article Title: Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Article Snippet: The association of syringocystadenoma papilliferum with verrucous carcinoma of the skin in the same lesion is a rare, but well-documented event.. Although human papilloma viruses have been proposed to have an etiologic role in the development of the verrucous proliferations associated with syringocystadenoma papilliferum, most of the immunohistochemical and molecular studies have failed to demonstrate the presence of their genomic material in these lesions.. We report a series of 4 cases of syringocystadenoma papilliferum associated with verrucous carcinoma in anogenital lesions. Article Title: The landscape of BRAF transcript and protein variants in human cancer Article Snippet: They were then incubated overnight at 4 °C with the following primary antibodies: anti-BRAF (F-7, #5284, Santa Cruz Biotechnology; mouse monoclonal antibody, dilution 1:1000 in 5% milk in TBST); Article Title: Investigation of FOXM1 as a Potential New Target for Melanoma Article Snippet: Sections of paraffin-embedded melanomas and nevus tissue samples were stained with a monoclonal mouse anti-FOXM1 antibody (clone 3A9; Abnova, Taipei, Taiwan), Article Title: Sessile Serrated Polyps are Precursors of Colon Carcinomas Predominantly with Deficient DNA Mismatch Repair Article Snippet: Staining for BRAF was performed with a Article Title: Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer. Article Snippet: Background.. BRAF mutation has been investigated by immunohistochemistry and has shown high sensitivity and specificity.. We aim to investigate the accuracy of immunohistochemistry versus molecular testing of BRAF in papillary thyroid cancer using a large number of polymerase chain reaction–positive BRAF papillary thyroid cancer tissues. Article Title: BRAF V600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 °C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Flow Cytometry:Article Title: BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 8C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Article Title: Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Article Snippet: Background: The BRAFV600E mutation is the most common genetic alteration in papillary thyroid carcinoma (PTC).. The aim of this study is to analyze the clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry (IHC) and BRAF RNA in situ hybridization (ISH) in PTC.. Methods: This study included 467 patients with PTC who underwent surgical resection. Article Title: Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Article Snippet: The association of syringocystadenoma papilliferum with verrucous carcinoma of the skin in the same lesion is a rare, but well-documented event.. Although human papilloma viruses have been proposed to have an etiologic role in the development of the verrucous proliferations associated with syringocystadenoma papilliferum, most of the immunohistochemical and molecular studies have failed to demonstrate the presence of their genomic material in these lesions.. We report a series of 4 cases of syringocystadenoma papilliferum associated with verrucous carcinoma in anogenital lesions. Article Title: The landscape of BRAF transcript and protein variants in human cancer Article Snippet: They were then incubated overnight at 4 °C with the following primary antibodies: anti-BRAF (F-7, #5284, Santa Cruz Biotechnology; mouse monoclonal antibody, dilution 1:1000 in 5% milk in TBST); Article Title: Investigation of FOXM1 as a Potential New Target for Melanoma Article Snippet: Sections of paraffin-embedded melanomas and nevus tissue samples were stained with a monoclonal mouse anti-FOXM1 antibody (clone 3A9; Abnova, Taipei, Taiwan), Article Title: Sessile Serrated Polyps are Precursors of Colon Carcinomas Predominantly with Deficient DNA Mismatch Repair Article Snippet: Staining for BRAF was performed with a Article Title: Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer. Article Snippet: Background.. BRAF mutation has been investigated by immunohistochemistry and has shown high sensitivity and specificity.. We aim to investigate the accuracy of immunohistochemistry versus molecular testing of BRAF in papillary thyroid cancer using a large number of polymerase chain reaction–positive BRAF papillary thyroid cancer tissues. Article Title: BRAF V600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 °C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Confocal Microscopy:Article Title: BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 8C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Article Title: Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Article Snippet: Background: The BRAFV600E mutation is the most common genetic alteration in papillary thyroid carcinoma (PTC).. The aim of this study is to analyze the clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry (IHC) and BRAF RNA in situ hybridization (ISH) in PTC.. Methods: This study included 467 patients with PTC who underwent surgical resection. Article Title: Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Article Snippet: The association of syringocystadenoma papilliferum with verrucous carcinoma of the skin in the same lesion is a rare, but well-documented event.. Although human papilloma viruses have been proposed to have an etiologic role in the development of the verrucous proliferations associated with syringocystadenoma papilliferum, most of the immunohistochemical and molecular studies have failed to demonstrate the presence of their genomic material in these lesions.. We report a series of 4 cases of syringocystadenoma papilliferum associated with verrucous carcinoma in anogenital lesions. Article Title: The landscape of BRAF transcript and protein variants in human cancer Article Snippet: They were then incubated overnight at 4 °C with the following primary antibodies: anti-BRAF (F-7, #5284, Santa Cruz Biotechnology; mouse monoclonal antibody, dilution 1:1000 in 5% milk in TBST); Article Title: Investigation of FOXM1 as a Potential New Target for Melanoma Article Snippet: Sections of paraffin-embedded melanomas and nevus tissue samples were stained with a monoclonal mouse anti-FOXM1 antibody (clone 3A9; Abnova, Taipei, Taiwan), Article Title: Sessile Serrated Polyps are Precursors of Colon Carcinomas Predominantly with Deficient DNA Mismatch Repair Article Snippet: Staining for BRAF was performed with a Article Title: Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer. Article Snippet: Background.. BRAF mutation has been investigated by immunohistochemistry and has shown high sensitivity and specificity.. We aim to investigate the accuracy of immunohistochemistry versus molecular testing of BRAF in papillary thyroid cancer using a large number of polymerase chain reaction–positive BRAF papillary thyroid cancer tissues. Article Title: BRAF V600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 °C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Blocking Assay:Article Title: BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 8C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Article Title: Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Article Snippet: Background: The BRAFV600E mutation is the most common genetic alteration in papillary thyroid carcinoma (PTC).. The aim of this study is to analyze the clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry (IHC) and BRAF RNA in situ hybridization (ISH) in PTC.. Methods: This study included 467 patients with PTC who underwent surgical resection. Article Title: Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Article Snippet: The association of syringocystadenoma papilliferum with verrucous carcinoma of the skin in the same lesion is a rare, but well-documented event.. Although human papilloma viruses have been proposed to have an etiologic role in the development of the verrucous proliferations associated with syringocystadenoma papilliferum, most of the immunohistochemical and molecular studies have failed to demonstrate the presence of their genomic material in these lesions.. We report a series of 4 cases of syringocystadenoma papilliferum associated with verrucous carcinoma in anogenital lesions. Article Title: The landscape of BRAF transcript and protein variants in human cancer Article Snippet: They were then incubated overnight at 4 °C with the following primary antibodies: anti-BRAF (F-7, #5284, Santa Cruz Biotechnology; mouse monoclonal antibody, dilution 1:1000 in 5% milk in TBST); Article Title: Investigation of FOXM1 as a Potential New Target for Melanoma Article Snippet: Sections of paraffin-embedded melanomas and nevus tissue samples were stained with a monoclonal mouse anti-FOXM1 antibody (clone 3A9; Abnova, Taipei, Taiwan), Article Title: Sessile Serrated Polyps are Precursors of Colon Carcinomas Predominantly with Deficient DNA Mismatch Repair Article Snippet: Staining for BRAF was performed with a Article Title: Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer. Article Snippet: Background.. BRAF mutation has been investigated by immunohistochemistry and has shown high sensitivity and specificity.. We aim to investigate the accuracy of immunohistochemistry versus molecular testing of BRAF in papillary thyroid cancer using a large number of polymerase chain reaction–positive BRAF papillary thyroid cancer tissues. Article Title: BRAF V600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 °C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Polymer:Article Title: BRAFV600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 8C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with Article Title: Clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry, and BRAF RNA in situ hybridization in papillary thyroid carcinoma. Article Snippet: Background: The BRAFV600E mutation is the most common genetic alteration in papillary thyroid carcinoma (PTC).. The aim of this study is to analyze the clinicopathologic correlations of the BRAFV600E mutation, BRAF V600E immunohistochemistry (IHC) and BRAF RNA in situ hybridization (ISH) in PTC.. Methods: This study included 467 patients with PTC who underwent surgical resection. Article Title: Syringocystadenoma papilliferum associated with verrucous carcinoma of the skin in the same lesion: Report of four cases. Article Snippet: The association of syringocystadenoma papilliferum with verrucous carcinoma of the skin in the same lesion is a rare, but well-documented event.. Although human papilloma viruses have been proposed to have an etiologic role in the development of the verrucous proliferations associated with syringocystadenoma papilliferum, most of the immunohistochemical and molecular studies have failed to demonstrate the presence of their genomic material in these lesions.. We report a series of 4 cases of syringocystadenoma papilliferum associated with verrucous carcinoma in anogenital lesions. Article Title: The landscape of BRAF transcript and protein variants in human cancer Article Snippet: They were then incubated overnight at 4 °C with the following primary antibodies: anti-BRAF (F-7, #5284, Santa Cruz Biotechnology; mouse monoclonal antibody, dilution 1:1000 in 5% milk in TBST); Article Title: Investigation of FOXM1 as a Potential New Target for Melanoma Article Snippet: Sections of paraffin-embedded melanomas and nevus tissue samples were stained with a monoclonal mouse anti-FOXM1 antibody (clone 3A9; Abnova, Taipei, Taiwan), Article Title: Sessile Serrated Polyps are Precursors of Colon Carcinomas Predominantly with Deficient DNA Mismatch Repair Article Snippet: Staining for BRAF was performed with a Article Title: Immunohistochemistry as an accurate tool for evaluating BRAF-V600E mutation in 130 samples of papillary thyroid cancer. Article Snippet: Background.. BRAF mutation has been investigated by immunohistochemistry and has shown high sensitivity and specificity.. We aim to investigate the accuracy of immunohistochemistry versus molecular testing of BRAF in papillary thyroid cancer using a large number of polymerase chain reaction–positive BRAF papillary thyroid cancer tissues. Article Title: BRAF V600E immunopositive Melanomas Show Low Frequency of Heterogeneity and Association With Epithelioid Tumor Cells Article Snippet: In brief, antigen retrieval was performed with EDTA (pH 9) using the PT link (Dako) for 10 minutes at 97 °C, subsequently followed by 5 minutes blocking with EnVision FLEX Peroxidase-Blocking Reagent, 20-minutes primary antibody incubation with |
